No Data
No Data
UNIQURE Earnings Results: $QURE Reports Quarterly Earnings
uniQure NV | 10-Q: Quarterly report
UniQure Reports Breakthrough Therapy Designation for AMT-130 and Financial Results for Q1 2025
uniQure NV | 8-K: uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
UniQure: Cash, Cash Equivalents and Current Investment Securities of $409M as of March 31 Expected to Fund Ops Into 2H of 2027 >QURE
Press Release: UniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress